Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.4.3 to Record History and removed Revision: v3.4.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision v3.4.2 was added to the Record History, replacing the previous v3.4.1. This update reflects a UI/versioning change in the history panel and does not alter trial data or statuses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe Record History now shows a new version entry v3.4.1 added and an older version v3.4.0 removed, reflecting a metadata update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedThe record history UI was updated to show a Show glossary option, introduce color-coded change highlights with a legend, and display a new revision label (v3.4.0) in place of the previous version.SummaryDifference1%

- Check59 days agoChange DetectedNew revision entry v3.3.4 was added to the Record History, alongside the existing v3.3.3 entry. This is a routine page update and does not modify study data or results.SummaryDifference0.1%

- Check80 days agoChange DetectedSite footer and revision metadata updated: 'Revision: v3.3.3' added; the 'HHS Vulnerability Disclosure' link and 'Revision: v3.3.2' entry removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.